Erdafitinib,Vinflunine,Docetaxel,Pembrolizumab
Janssen,pierre fabre,Merck
[]
my thoughts about thor at #asco23: change practice (need for fgfr testing) ideal vs pragmatic tumor origin &amp; timing for testing? couldn t see long lasting survivors in fact, no long term responders lack of consistency in definition of fgfr alt across other fgfrinh data
Jefe del Servicio de #Oncología Médica y Director de Investigación Clínica de la Fundación MD Anderson Cancer Center Madrid. Opinions are my own